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S U M M A R Y
Background: Scrub typhus, a bacterial zoonosis caused by Orientia tsutsugamushi, may cause multiorgan
dysfunction syndrome (MODS) and is associated with signiﬁcant mortality. This study was undertaken
to document the clinical and laboratory manifestations and complications and to study time trends and
factors associated with mortality in patients with scrub typhus infection.
Methods: This retrospective study, done at a university teaching hospital, included 623 patients
admitted between 2005 and 2010 with scrub typhus. The diagnosis was established by a positive IgM
ELISA and/or pathognomonic eschar with PCR conﬁrmation where feasible. The clinical and laboratory
proﬁle, course in hospital, and outcome were documented. Factors associated with mortality were
analyzed using multivariate logistic regression analysis.
Results: The most common presenting symptoms were fever (100%), nausea/vomiting (54%), shortness
of breath (49%), headache (46%), cough (38%), and altered sensorium (26%). An eschar was present in
43.5% of patients. Common laboratory ﬁndings included elevated transaminases (87%), thrombocyto-
penia (79%), and leukocytosis (46%). MODS was seen in 34% of patients. The overall case-fatality rate was
9.0%. Features of acute lung injury were observed in 33.7%, and 29.5% required ventilatory support. On
multivariate analysis, shock requiring vasoactive agents (relative risk (RR) 10.5, 95% conﬁdence interval
(CI) 4.2–25.7, p < 0.001), central nervous system (CNS) dysfunction (RR 5.1, 95% CI 2.4–10.7, p < 0.001),
and renal failure (RR 3.6, 95% CI 1.7–7.5, p = 0.001) were independent predictors of mortality. Over 4
years, a decreasing trend was observed in the mortality rate.
Conclusions: Scrub typhus can manifest with potentially life-threatening complications such as lung
injury, shock, and meningoencephalitis. MODS occurred in a third of our patients. The overall case-
fatality rate was 9%, with shock, renal failure, and CNS associated with a higher mortality.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Scrub typhus is an acute febrile illness endemic to the
‘tsutsugamushi triangle’, which encompasses broad areas of south
and southeastern Asia, the Asian Paciﬁc Rim, and northern Australia,
with a population of over one billion people.1 This infection is caused
by the obligate intracellular Gram-negative bacterium Orientia* Corresponding author. Tel.: +91 9487393015; fax: +0416 2232035.
E-mail address: georgemvarghese@hotmail.com (G.M. Varghese).
http://dx.doi.org/10.1016/j.ijid.2014.02.009
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).tsutsugamushi, which was previously categorized in the Rickettsia
genus.2 During the Second World War, scrub typhus caused major
epidemics resulting in signiﬁcant morbidity and mortality in the
border regions of India and Burma.3 Although reports of the disease
were rare for several decades, a clear re-emergence has been
documented from several states in India, including Himachal
Pradesh, Tamil Nadu, Kerala, Maharashtra, Bihar, Karnataka, Jammu
and Kashmir, Uttaranchal, Rajasthan, West Bengal, and Megha-
laya.4–7 In some regions, scrub typhus accounts for up to 50% of
undifferentiated fever presenting to the hospital, and more than one
million people are affected worldwide annually.8,9ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Diagnostic criteria for organ dysfunction syndromea
Organ system Diagnostic criteria
Pulmonary  Moderate or severe hypoxia (PaO2 <60 mmHg/SaO2 <90%)
 PaO2/FiO2 <300 mmHg (40 kPa)
 Need for ventilatory assistance
Renal  Creatinine 2.5 mg/dl
Cardiovascular  Blood pressure <80/60 mmHg despite ﬂuid resuscitation
 Need for vasopressor support in spite of ﬂuid resuscitation
Hepatic  Total bilirubin 2.5 mg/dl
CNS  GCS 8/15 or 5T/10
CNS, central nervous system; Glasgow Coma scale score.
a Multiorgan dysfunction syndrome (MODS) is deﬁned as dysfunction of two or
more organ systems.
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stage of the trombiculid mite (chigger) of the Leptotrombidium
genus, which typically feeds on wild rats.10 O. tsutsugamushi is
injected into the human host from the chigger’s digestive system. It
subsequently adheres to and invades the host’s phagocytes and
endothelial cells, possibly by means of the 56-kDa type-speciﬁc
antigen (TSA) protein, the transmembrane protein unique to this
organism. Once inside these cells, as with other rickettsial illnesses,
an acute vasculopathy ensues, which can affect a broad range of
organs, leading to various potentially life-threatening complica-
tions.
Acute fever is the most common presenting symptom, often
associated with breathlessness, cough, nausea, vomiting, myalgia,
and headache.11,12 An eschar at the site of inoculation can be found,
if searched for thoroughly, in a highly variable percentage of people
(10–92%).13 The infection can range from a self-limiting disease to
a fatal illness in 35–50% of cases, with multiorgan dysfunction, if
not promptly diagnosed and appropriately treated.14 Severe
complications, including acute respiratory distress syndrome
(ARDS), hepatitis, renal failure, meningoencephalitis, and myocar-
ditis with shock, may occur in varying proportions of patients. The
vast variability and non-speciﬁc presentation of this infection have
often made it difﬁcult to diagnose clinically. Basic laboratory tests,
such as complete blood counts, which are relied on to give
diagnostic clues, are often normal, although thrombocytopenia is
very common.5,15 One of the most consistent laboratory ﬁndings in
scrub typhus is a mild transaminitis, which has been reported in
the majority of patients in several studies (66.7% to >90%).4,5,11
Renal dysfunction, as evidenced by an elevation in creatinine, has
also shown a high degree of variability in previous research,
although most studies have reported it to be present in 10–20%.4,5
Diagnostic tests such as the Weil–Felix test are very insensitive and
non-speciﬁc.16 The current choice for the serologic diagnosis is IgM
ELISA testing or immunoﬂuorescence assay (IFA), which is
considered the gold standard, although it is less frequently
available.
The goal of this retrospective study was to provide a detailed
panel of clinical aspects of this disease based on a large patient
population, thus helping to create a better clinical and laboratory
proﬁle of this reemerging disease for clinicians to work with. We
also set out to study the trend in mortality over time. Compared to
our previous prospective analysis,17 we have included substan-
tially more patients and are thus able to present a more precise
clinical picture and mortality trend, which is the focus of this work.
Patients from the previous analysis were included in this current
data.17
2. Methods
Patients over the age of 16 years admitted with scrub typhus to
the Christian Medical College, Vellore, a 2700-bed medical college
hospital, between 2005 and 2010, were included in this retrospec-
tive study. The diagnosis was conﬁrmed through serum IgM ELISA
scrub typhus and/or presence of an eschar with PCR conﬁrmation.
Data were collected regarding patient demographics, clinical
features, vital parameters, laboratory data (complete blood counts,
serum creatinine, and liver function tests), chest radiography
ﬁndings, duration of hospital stay, duration of ventilation, need for
dialysis, complications, and outcome on a predesigned data
abstraction form. The nature and extent of organ dysfunction
was also noted. Multiorgan dysfunction syndrome (MODS) was
diagnosed as per established criteria (Table 1). MODS was deﬁned
as the simultaneous or sequential development of potentially
reversible physiological derangement involving two or more organ
systems (respiratory, cardiovascular, renal, hepatic, and neurolog-
ical systems). IgM ELISA was performed on serum samples usingthe Scrub Typhus Detect test (InBios International, Inc., Seattle,
WA, USA) as per the manufacturer’s instructions. An optical
density (OD) >0.5 was considered positive.
2.1. PCR analysis
Eschar samples were used for PCR. Bacterial DNA, extracted
using a QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) in
accordance with the manufacturer’s instructions, was used as the
template for the PCR. A standard PCR targeting the 56-kDa protein
was carried out as reported previously,4 using the oligonucleotide
primers OtsuF 50-AATTGCTAGTGCAATGTCTG-30, and OtsuR 50-
GGCATTATAGTAGGCTGAG-30. The expected amplicon size was
410 bp.
2.2. Statistical analysis
Statistical analysis was performed using SPSS software for
Windows version 16.0 (SPSS Inc., Chicago, IL,USA). Descriptive data
are given as the mean  standard deviation (SD), or as the median
and interquartile range (IQR). The Chi-square test or Fisher’s exact
test was used to compare dichotomous variables and the t-test or
Mann–Whitney test was used for continuous variables, as appropri-
ate. The associations of clinical and laboratory features with the
outcome were analyzed by univariate and multivariate logistic
regression, and 95% conﬁdence intervals were calculated. For all tests,
a two-sided p-value of 0.05 or less was considered statistically
signiﬁcant.
3. Results
Six hundred twenty-three patients admitted with scrub typhus
during the 5-year study period were included. The proportions of
males and females were almost equal (48% vs. 52%). The mean age
of patients was 45  15 years and the mean duration of illness before
presentation to the hospital was 9.6  4.8 days. Agricultural laborers
comprised 41% of the total patient population. The most common
presenting symptoms were fever (100%), nausea/vomiting (54%),
shortness of breath (49%), headache (46%), cough (38%), and altered
sensorium (26%). An eschar was noted in 43.5% of patients. Common
laboratory ﬁndings included elevated transaminases (87%), throm-
bocytopenia (79%), and leukocytosis (46%). The transaminitis tended
to be mild (2–3 times the normal values). Creatine phosphokinase
(CPK) levels were found to be high in the group with MODS as
compared to the group with no MODS (mean value 1336 vs. 135 IU/l,
respectively; p < 0.001). The overall case-fatality rate was 9.0%. The
patient characteristics are provided in Table 2.
About a third of patients (34%) had evidence of MODS. The case-
fatality rate for those who developed MODS was signiﬁcantly
higher than that for those who did not (25% vs. 0.7%, p < 0.001).
Among those with MODS, respiratory system dysfunction occurred
Table 2
Patient characteristics
Patient characteristics Multiorgan dysfunction present
n = 212 (34%)
Multiorgan dysfunction absent
n = 411 (66%)
Age, years, mean  SD 45.6  14.8 44  15.8
Sex male/female, n/n 96/116 204/207
Occupation, n (%)
Agricultural worker 87 (41.0) 176 (42.8)
Other 125 (58.9) 235 (57.1)
Duration of illness before admission, days, median (IQR) 8 (1–45) 10 (1–45)
Pre-morbid conditions, n (%)
Diabetes mellitus 24 (11.3) 47 (11.4)
Hypertension 29 (13.7) 46 (11.2)
COPD/asthma 5 (2.4) 10 (2.4)
Chronic renal failure 2 (0.9) 2 (0.5)
Pregnancy 10 (4.7) 14 (3.4)
Clinical symptoms and signs, n (%)
Headache 69 (32.5) 216 (52.6)
Altered sensorium 62 (29.2) 99 (24.1)
Seizures 27 (12.7) 31 (7.5)
Nausea/vomiting 109 (51.4) 226 (55.0)
Myalgia 34 (16.0) 86 (20.9)
Diarrhea 35 (16.5) 57 (13.9)
Cough 88 (41.5) 149 (36.3)
Shortness of breath 156 (73.6) 147 (35.8)
Rash 7 (3.3) 10 (2.4)
Eschar 98 (46.2) 173 (42.1)
Heart rate/min, mean  SD 105  19 96  14
Systolic blood pressure, mmHg, mean  SD 106  17 114  15
Laboratory values
Hemoglobin, g/dl, mean  SD 11.8  2.5 11.8  2.2
WBC count, 109/l, median (IQR) 11.65 (1.20–50.00) 9.80 (1.90–36.60)
Platelet count, 109/l, median (IQR) 51 (5–343) 95 (3–529)
Bilirubin, mg/dl, median (IQR) 2.6 (0.3–30.9) 0.8 (0.2–14.4)
Total protein, g/dl, mean  SD 5.8  0.7 6.5  0.8
Albumin, g/dl, mean  SD 2.3  0.5 2.8  0.6
AST, IU/l, median (IQR) 156 (14–2698) 116 (12–1839)
ALT, IU/l, median (IQR) 83 (12–1775) 80 (10–753)
ALP, IU/l, median (IQR) 187 (58–975) 122 (24–715)
Serum creatinine, mg/dl, median (IQR) 1.8 (0.6–12.5) 1 (0.4–5.7)
CPK, IU/l, median (IQR) 184 (21–22 234) 87 (20–140 500)
Case-fatality, n (%) 53 (25) 3 (0.7)
SD, standard deviation; IQR, interquartile range; COPD, chronic obstructive pulmonary disease; AST, aspartate transaminase; ALT, alanine transaminase; ALP, alkaline
phosphatase; CPK, creatine phosphokinase.
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68.9%. Hepatic dysfunction with bilirubin >2 mg/dl was found in
63.7%. Shock requiring vasoactive agents was present in 65.6% of
cases, meningitis or meningoencephalitis in 15.6%, central nervous
system (CNS) dysfunction (Glasgow coma scale (GCS) score 8/15)
in 31%, and renal failure with creatinine >2 mg/dl in 44.3% of the
patients with MODS (Table 3).
Univariate analysis showed that CNS dysfunction, elevated
bilirubin and alkaline phosphatase, shock requiring vasoactive
agents, requirement for ventilator support, and renal failure were
associated with a poor outcome (Table 4). Among these, shock
requiring vasoactive agents (relative risk (RR) 10.5, 95% conﬁdenceTable 3
Organ system dysfunction in patients with scrub typhus
Complication No. (%) MODS
present
MODS
absent
ARDS 210 (33.7) 163 (76.9) 47 (11.4)
Shock requiring inotropic support 144 (23.1) 139 (65.6) 5 (1.2)
Hepatitisa 212 (34) 135 (63.7) 77 (18.7)
Meningoencephalitis 145 (23.3) 33 (15.6) 112 (27.3)
Renal failureb 112 (18) 94 (44.3) 18 (44)
Invasive ventilation 184 (29.5) 146 (68.9) 38 (9.2)
CNS dysfunction 71 (11.4) 66 (31.3) 5 (1.2)
MODS, multiorgan dysfunction syndrome; ARDS, acute respiratory distress
syndrome; CNS, central nervous system.
a Bilirubin 2 mg/dl.
b Serum creatinine 2 mg/dl.interval (CI) 4.2–25.7, p < 0.001), CNS dysfunction (RR 5.1, 95% CI
2.4–10.7, p < 0.001), and renal dysfunction (RR 3.6, 95% CI 1.7–7.5,
p = 0.001) were found to be independent predictors of mortality on
multivariate analysis using the forward method (Table 5). The
mortality rate over 4 years showed a downward trend from 14.6%
to 7.6% (Figure 1).
4. Discussion
Scrub typhus is a potentially fatal infection that affects about
one million people every year.9 Our patients presented to the
hospital with a mean duration of illness of 9 days, with symptoms
of fever, nausea/vomiting, shortness of breath, cough, headache,
and altered mental status. About a third of our patients had
evidence of MODS and the overall mortality was 9%, with shock
requiring vasoactive agents, CNS dysfunction, and renal failure
being independent predictors of mortality.
This overall case-fatality in our study of 9.0% is lower than the
14% previously reported from our own institution in 2002–2003.18
In the present study, analysis of the mortality trend over the 4-year
period showed the mortality rate to have halved from 14.6% in
2007 to 7.3% and 7.6% in 2009 and 2010, respectively. Reports from
northern India have also shown a trend towards decreasing
mortality, with a rate of 17.2% reported in 2004 and 14% reported
in 2006.4,19 This trend may primarily be due to increased
awareness and early recognition and treatment of the cases by
physicians.
Table 4
Predictors of mortality (univariate analysis)
Dead
n = 56 (8.9%)
Alive
n = 567 (91%)
RR (CI) p-Value
Duration of illness, days, mean  SD 7.86  3.8 9.76  4.9 0.9 (0.82–0.96) 0.004
Altered sensorium, n (%) 27 (48.2) 134 (23.6) 3 (1.7–5.2) <0.001
Seizures, n (%) 12 (21.4) 46 (8.1) 3.1 (1.5–6.3) 0.002
Shortness of breath, n (%) 42 (75) 261 (46) 3.5 (1.8–6.5) <0.001
Heart rate/min, mean  SD 112.6  20.1 97.9  15.8 1.04 (1.03–1.06) 0.001
Systolic BP 90 mmHg at admission, n (%) 16 (28.5) 70 (12.3) 2.8 (1.5–5.3) 0.001
WBC count, 109/l, median (IQR) 15.5178 (2.200–42.100) 10.785 (1.200–50.000) 1.00 (1.00–1.00) <0.001
Platelet count, 109/l, median (IQR) 65.268 (6.000–331.000) 100.051 (3.000–529.000) 1.00 (1.00–1.00) 0.002
Bilirubin 2.5 mg/dl, n (%) 33 (58.9) 179 (31.6) 3.1 (1.7–5.4) <0.001
AST, IU/l, median (IQR) 241.9 (31–2698) 171.1 (12–1850) 1.001 (1–1.002) 0.02
ALT, IU/l, median (IQR) 104.6 (20–823) 105.8 (10–1775) 1 (0.99–1.003) 0.93
ALP, IU/l, median (IQR) 226.3 (66–594) 178.8 (24–975) 1.002 (1.001–1.004) 0.01
ARDS, n (%) 38 (67.9) 172 (30.3) 4.8 (2.7–8.7) <0.001
Hypotension requiring inotropic support, n (%) 47 (83.9) 97 (17.1) 25.3 (12–53.3) <0.001
Serum creatinine 2.5 mg/dl, n (%) 32 (57.1) 80 (14.1) 8.1 (4.5–14.5) <0.001
CNS dysfunction, n (%) 32 (57.1) 39 (6.9) 18.1 (9.6–33.6) <0.001
Requiring ventilatory support, n (%) 48 (85.7) 136 (24) 19.01 (8.7–41.2) <0.001
RR, relative risk; CI, conﬁdence interval; SD, standard deviation; BP, blood pressure; WBC, white blood cell; IQR, interquartile range; AST, aspartate transaminase; ALT, alanine
transaminase; ALP, alkaline phosphatase; ARDS, acute respiratory distress syndrome; CNS, central nervous system.
Table 5
Independent predictors of mortality
Independent predictors 95% CI p-Value
Hypotension requiring inotropes 10.1 (4.5–22.9) <0.001
Creatinine >2 mg/dl 3.5 (1.7–7.1) 0.001
CNS dysfunction 6 (2.8–12.8) <0.001
Bilirubin >2 mg/dl 1.4 (0.7–2.8) 0.36
Ventilation 2.2 (0.76–6.7) 0.14
CI, conﬁdence interval; CNS, central nervous system.
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our patients. Pulmonary dysfunction was the most common
complication (33.7%), and the majority of these patients (69%)
required invasive ventilator support. Previous studies from India
have shown an incidence of ARDS of 8–10%.4,12 The case-fatality
rate in those with ARDS was 18% in our study as compared to a
higher rate (25%) seen in prior work.20 Acute renal failure was seen
in 18% of our patients. This incidence of renal impairment is lower
than the 23.2% incidence reported by Attur et al.21 and much lower
than the 66.4% incidence reported by Mahajan et al.4 Our incidence
of meningoencephalitis (23.3%) was found to be higher than the
9.5% and 14% reported in other studies from India.4,12 Cases with
meningitis had a lower rate of mortality, at 6.2%, than the higher
rates among cases with renal impairment (57%), pulmonaryFigure 1. Mortality trend over the 4 years 2007–2010.complications (68%), hypotension requiring inotropes (84%), and
hepatitis (59%). Our study revealed practically relevant complica-
tions such as renal failure, hypotension requiring inotropes, and
CNS dysfunction to be independent predictors of mortality. This
adds to prior works, which have identiﬁed the absence of an eschar,
intensive care unit admission, and high APACHE II score to be
independent predictive variables associated with a fatal out-
come.22,23
The occupation and scrub vegetations surrounding the house of
the patients are known to have a strong association with
acquisition of the infection.24 In this study, 42% of the patients
were agricultural laborers and 36% housewives, indicating an
increased risk of infection in those who encounter scrub vegetation
in their daily life. Our rate of ﬁnding an eschar, in 43.5% of patients,
is similar to that reported from other studies that have been
performed close to this geographic area, with an eschar noted in
46% of patients by Vivekanandan et al. in Pondicherry.12 However,
in North India, Mahajan et al. reported ﬁnding an eschar in only
9.5% of patients,4 while in Korea an eschar has been documented in
as many as 90% of patients.22 The variation in prevalence of an
eschar may represent the different geographic distribution of the
various strains of the organism, or inadequate search for the
eschar; further research is warranted in this area.25
The ﬁnding of mild hepatitis in 87% of our patients is consistent
with previous reports.4,5,11 Thrombocytopenia was also noted in
similar percentages of patients as in previous studies.5 However,
data reported from northern China suggest signiﬁcantly lower
rates of thrombocytopenia, ranging from 4.6% to 48.9%.15 This may
partly be explained by the lower threshold used in their study (100
vs. 150  109/l), as studies done in Pondicherry, near our center,
also found lower rates (10%) with the same lower threshold. The
observed thrombocytopenia does tend to be mild in this
disease:5,12 about 60% of our patients had platelet counts
<100  109/l and only 19.5% had severe thrombocytopenia
(<30  109/l). Leukocytosis (>11  109/l), a common sign of
bacterial etiology, was found in less than 50% (42.6%) of our
patients. This ﬁnding was present in an even lower percentage of
patients in the study by Liu et al. in northern China (10.5%).15
However, the result of the leukocyte count was very inhomoge-
neous in our study, with a range from minimum 1.2  109/l to
maximum 50  109/l.
One of the limitations of our study is that strain variation and
the virulence of infecting strains, which have earlier been reported
to be associated with the severity of the symptoms and clinical
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investigations focusing on the types of circulating strain are
imperative to obtain a complete clinical proﬁle of this infection.
The study may also be limited by the inherent disadvantages of a
retrospective study design from a single medical center, such as the
bias in patient selection or referral and the potentially incomplete
data available for some of the patients.
In conclusion, scrub typhus is a serious acute febrile illness
associated with signiﬁcant mortality. Respiratory dysfunction,
shock, and acute renal failure are serious life-threatening
complications of this disease. Mortality is signiﬁcantly higher
in patients with CNS dysfunction or renal failure, and in those
requiring vasoactive agents for shock. Scrub typhus is present in
regions that are co-endemic for diseases that may present with
similar clinical syndromes, such as malaria, dengue, typhoid, and
leptospirosis. The mortality from this infection does appear to
have been decreasing over the last several years. However,
developing increasing awareness of this infection among clin-
icians in endemic settings and reliable methods for more rapid
diagnosis will be the key to further reducing the mortality caused
by this deadly disease.
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